You are using an older browser version. Please use a supported version for the best MSN experience.

Torrent Pharma's Gujarat Facility Gets U.S FDA Observation, Lupin's Tarapur Unit Gets Warning Letter

Torrent Pharmaceuticals said that the US FDA issued Form 483 to the company with 3 observations post the inspection of the drug maker's Indrad-based manufacturing facility.In an exchange filing made after market hours on Thursday, the company said that the United States Food and Drug Administration (US FDA) had inspected its manufacturing facility at Indrad, Gujarat from 19 September 2022 to 28 September 2022.Meanwhile, the United States Food and Drug Administration (US FDA) has also issued a warning letter to Lupin's Tarapur, Maharashtra facility. #torrentpharma #lupin #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday About CNBC-TV18:

UP NEXT

UP NEXT

More From CNBCTV18

More From CNBCTV18

image beaconimage beaconimage beacon